Moderna (NASDAQ: MRNA) ranks as one of the biggest winners of the coronavirus vaccine race. The stock has skyrocketed, but has it gone up too much? In this Motley Fool Live video recorded on Jan. 6, 2021, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights discuss whether or not Moderna is overvalued after its impressive run.
Is Moderna Stock Overvalued?
Latest from Blog
Marijuana stocks have been on fire lately. Many investors are hoping that a Democratic-controlled senate will…
If investors entered 2020 unsure of their convictions, they know them now. The unprecedented uncertainty created…
Are you looking for a great dividend stock to add to your portfolio? There are many…
When you consider Wells Fargo‘s (NYSE: WFC) fake accounts scandal, where more than 3 million accounts…
DocuSign (NASDAQ: DOCU) has certainly grown impressively, and investors have been handsomely rewarded. Since its 2018…